Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Net Cash Flow (2024 - 2025)

Historic Net Cash Flow for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to -$582000.0.

  • Kairos Pharma's Net Cash Flow fell 296315.79% to -$582000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is 44273.26% up from last year.
  • Per Kairos Pharma's latest filing, its Net Cash Flow stood at -$582000.0 for Q2 2025, which was down 296315.79% from $2.3 million recorded in Q1 2025.
  • Over the past 5 years, Kairos Pharma's Net Cash Flow peaked at $3.2 million during Q3 2024, and registered a low of -$1.9 million during Q4 2024.